Month 1 Post- and Month 2 Post-Treatment Evaluations
At 1 and 2 months after the last study treatment administration, the following procedures and assessments will be conducted by the Principal Investigator, psychometrician and/or cognitive rater:
Medical Measurements
Height
Weight
Blood pressure
Month 1 - Cognitive Assessments and Subject/Study Partner Interviews
Neuropsychiatric Inventory Questionnaire (NPI)
Clinical Dementia Rating Scale (CDR)
Modified Activities of Daily Living (ADL) Inventory
Month 2 – Cognitive Assessments and Subject/Study Partner Interviews
The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the
Magneceutical®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.